World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 20 June 2016
Main ID:  NCT01603199
Date of registration: 17/05/2012
Prospective Registration: No
Primary sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Public title: High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
Scientific title: Impact of a High-protein High-fiber Diet on the Nutritional Status of Patients With Primary Biliary Cirrhosis
Date of first enrolment: September 2011
Target sample size: 36
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01603199
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care  
Phase:  N/A
Countries of recruitment
Mexico
Contacts
Name:     Aldo Torre Delgadillo, M.D. M.Sc
Address: 
Telephone:
Email:
Affiliation:  INCMNSZ
Key inclusion & exclusion criteria

Inclusion Criteria:

- Controls

Diagnose of primary biliary cirrhosis:

- Biochemical evidence of cholestasis: based mainly on alkaline phosphatase elevation

- Presence of antimitochondrial antibodies (AMA)

- Histologic evidence of nonsuppurative destructive cholangitis and destruction of
interlobular bile ducts.

Ambulatory patients

- Cases

Diagnose of primary biliary cirrhosis:

- Biochemical evidence of cholestasis: based mainly on alkaline phosphatase elevation

- Presence of antimitochondrial antibodies (AMA)

- Histologic evidence of nonsuppurative destructive cholangitis and destruction of
interlobular bile ducts.

Diagnose of liver cirrhosis by two or more of the following criteria:

- Albumin < 3.4 g/dL

- INR = 1.3

- Total bilirubin = 2 mg/dL

- Portal hypertension (esophageal varices, splenomegaly, ascites, etc.)

- Liver biopsy Ambulatory patients

Exclusion Criteria:

- Overlapping syndrome with predominant autoimmune hepatitis

- Hospitalized patients

- Acute or chronic renal failure

- Hepatocellular carcinoma

- Pregnancy

- Neuropsychiatric disorders (Schizophrenia, bipolar disorder, dementia and
attention-deficit hyperactivity disorder)



Age minimum: 18 Years
Age maximum: 70 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Primary Biliary Cirrhosis
Intervention(s)
Dietary Supplement: High protein high fiber diet
Primary Outcome(s)
Nutritional status [Time Frame: Participants will be followed for 6 months]
Secondary Outcome(s)
Quality of life [Time Frame: Participants will be followed for 6 months]
Minimal hepatic encephalopathy [Time Frame: Participants will be followed for 6 months]
Secondary ID(s)
GAS-460-11/12-1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history